Beyond tradition and convention: benefits of non-traditional model organisms in cancer research
- PMID: 33111160
- DOI: 10.1007/s10555-020-09930-6
Beyond tradition and convention: benefits of non-traditional model organisms in cancer research
Abstract
Traditional laboratory model organisms are indispensable for cancer research and have provided insight into numerous mechanisms that contribute to cancer development and progression in humans. However, these models do have some limitations, most notably related to successful drug translation, because traditional model organisms are often short-lived, small-bodied, genetically homogeneous, often immunocompromised, are not exposed to natural environments shared with humans, and usually do not develop cancer spontaneously. We propose that assimilating information from a variety of long-lived, large, genetically diverse, and immunocompetent species that live in natural environments and do develop cancer spontaneously (or do not develop cancer at all) will lead to a more comprehensive understanding of human cancers. These non-traditional model organisms can also serve as sentinels for environmental risk factors that contribute to human cancers. Ultimately, expanding the range of animal models that can be used to study cancer will lead to improved insights into cancer development, progression and metastasis, tumor microenvironment, as well as improved therapies and diagnostics, and will consequently reduce the negative impacts of the wide variety of cancers afflicting humans overall.
Keywords: Cancer; Cancer resistance; Metastasis; Non-traditional model organisms; Sentinel; Spontaneous tumors; Tumor microenvironment.
References
-
- Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590 . - DOI
-
- Oppermann, H., Levinson, A. D., Varmus, H. E., Levintow, L., & Bishop, J. M. (1979). Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (Src). Proceedings of the National Academy of Sciences of the United States of America, 76(4), 1804–1808. https://doi.org/10.1073/pnas.76.4.1804 . - DOI - PubMed - PMC
-
- Irby, R. B., & Yeatman, T. J. (2000). Role of Src expression and activation in human cancer. Oncogene, 19(49), 5636–5642. https://doi.org/10.1038/sj.onc.1203912 . - DOI - PubMed
-
- Weiss, R. A., & Vogt, P. K. (2011). 100 years of Rous sarcoma virus. The Journal of Experimental Medicine, 208(12), 2351–2355. https://doi.org/10.1084/jem.20112160 . - DOI - PubMed - PMC
-
- Ferreira, R., Limeta, A., & Nielsen, J. (2019). Tackling cancer with yeast-based technologies. Trends in Biotechnology, 37(6), 592–603. https://doi.org/10.1016/j.tibtech.2018.11.013 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
